SCHEMBL15918073

SCHEMBL15918073

CCC(Cl)S(=O)(=O)c1ncccc1Br

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 2/20 0.34
▸ FEN1 P39748 2/20 0.34
▸ KMT2A Q03164 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ APOBEC3G Q9HC16 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ COMT P21964 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CDC25B P30305 1/20 0.31
▸ NFE2L2 Q16236 2/20 0.31
▸ THRA P10827 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ PAX8 Q06710 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ PLCG1 P19174 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15916010 0.84 ALOX5AP (0.46) ALOX5APFEN1KMT2AKDM4EGAA
SCHEMBL15916561 0.80 ALOX5AP (0.42) ALOX5APFEN1KMT2ACDC25BNFE2L2
SCHEMBL13491148 0.73 KMT2A (0.39) KMT2AGAATDP1CDC25BNFE2L2
SCHEMBL937654 0.73 TRPV4 (0.39) KMT2AGAATDP1ALDH1A1CDC25B
SCHEMBL14120534 0.71 CA2 (0.45) KMT2AKDM4EMAPTALDH1A1CDC25B
SCHEMBL28009617 0.70 COMT (0.40) KMT2AKDM4EGAAMAPTTDP1
SCHEMBL15915531 0.69 ALOX5AP (0.42) ALOX5APFEN1KMT2AKDM4EGAA
SCHEMBL15917814 0.69 PLCG1 (0.34) ALOX5APFEN1KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL28047305 0.68 COMT (0.39) KMT2AKDM4EMAPTTDP1COMT
SCHEMBL15916605 0.68 TDP1 (0.44) ALOX5APFEN1TDP1COMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495359-A1 FLAP MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 — — EP disclosed
EP-3070085-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 — — EP disclosed
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 — — EP disclosed
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 — — US disclosed
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 — — US disclosed
EP-3070085-A1 FLAP MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-09-21 — — EP disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 — — US disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 — — US disclosed
US-9079866-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 — — US disclosed
US-20140221311-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 95/4885FEN1 1/4885KMT2A 3635/4885
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R ALOX5AP 80/4885FEN1 2/4885KMT2A 3824/4885
US-20140221311-A1 FLAP MODULATORS PGF, FEN1, TBXA2R ALOX5AP 80/4885FEN1 2/4885KMT2A 3824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback